ON DEMAND 2024 Midwest Conference - SGLT2-I in Heart Failure Management
CE Information
1.0 contact hour (1.0 pharmacology)Completion Time
44 minutesAvailable Until
December 31, 2025
Navigate
Overview
Specialties
AdultSubspecialties
CardiovascularClinical Topics
Cardiovascular Disease and Heart DiseaseHeart failure (HF) represents a significant burden on global healthcare systems, with increasing prevalence and mortality rates. Traditional therapies have provided symptomatic relief, but there remains a pressing need for interventions that not only improve symptoms but also reduce mortality and hospitalizations. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed for type 2 diabetes management, have recently emerged as a promising therapeutic avenue for HF. This presentation aims to delve into the evolving landscape of SGLT2 inhibitors in the context of HF management. The mechanisms of action, including their effects on glucose metabolism, hemodynamics, and myocardial energetics. Additionally, we will examine the robust clinical evidence supporting their efficacy and safety profiles in HF patients.
Learning Objectives
- Understand the Mechanism of Action of SGLT2 Inhibitors
- Review the Clinical Evidence Supporting SGLT2 Inhibitors in Heart Failure
- Discuss the integration of SGLT2 Inhibitors into Clinical Practice for Heart Failure Management
Learning Outcome Evaluation: Participants will state one thing they learned from the program and how they will implement it into their practice.
Speakers
Dr Baker is an Adult Acute Care Clinical Nurse Specialist with over 20 years of nursing experience. She is an assistant professor at Purdue University Northwest, teaching both undergraduate and graduate levels. Her specialties include cardiology and acute and critical care. She practices as an APRN at Advocate Medical Group Cardiology as a provider.
CE Information
This activity offers 1.0 contact hour (1.0 pharmacology) to attendees.
Accredited by Illinois Nurses Foundation is approved as a provider of nursing continuing professional development by the Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
The Illinois Nurses Foundation and the Illinois Society for Advanced Practice Nursing jointly provided this program.
Disclosures
To earn contact hours, learners must watch the entire webinar and submit an evaluation to receive the digital certificate after the session.
There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity
Activity Content
Registration to this activity includes access to the following supporting materials.
- SGLT2-I in Heart Failure Management (Size: 1.96 MB)
Duration: about 1 hour | Quality: HD
4 questions
Access your certificate